Binding molecules for bcma and cd3
US-2025346684-A1 · Nov 13, 2025 · US
This page is not indexed by search engines while we improve data quality.
Kufer Peter patents
Kufer Peter is listed as an inventor on 114 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Kufer Peter |
| Total patents | 114 |
| First publication | Jan 22, 2015 |
| Latest publication | Nov 13, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Antibody constructs for dll3 and cd3
US-2025340639-A1 · Nov 6, 2025 · US
Psma and cd3 bispecific t cell engaging antibody constructs
US-2025333537-A1 · Oct 30, 2025 · US
Bispecific single chain antibody construct with enhanced tissue distribution
US-2025333535-A1 · Oct 30, 2025 · US
Antibody constructs for CDH19 and CD3
US-12441796-B2 · Oct 14, 2025 · US
Antibody constructs for DLL3 and CD3
US-12435139-B2 · Oct 7, 2025 · US
PSMA and CD3 bispecific T cell engaging antibody constructs
US-12428491-B2 · Sep 30, 2025 · US
Antibody constructs for msln and cd3
US-2025282863-A1 · Sep 11, 2025 · US
Bispecific t cell engaging antibody constructs
US-2025163177-A1 · May 22, 2025 · US
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
US-2025163179-A1 · May 22, 2025 · US
Recent patents
Latest publications not already listed above.
Antibody constructs for DLL3 and CD3
US-12304952-B2 · May 20, 2025 · US
Antibody constructs for CDH19 and CD3
US-12297292-B2 · May 13, 2025 · US
Cross-species-specific PSMAxCD3 bispecific single chain antibody
US-12281172-B2 · Apr 22, 2025 · US
Binding molecules for BCMA and CD3
US-12281175-B2 · Apr 22, 2025 · US
Binding molecules for BCMA and CD3
US-12281176-B2 · Apr 22, 2025 · US
Bispecific antibody constructs for cdh3 and cd3
US-2025092133-A1 · Mar 20, 2025 · US
Compositions comprising cross-species-specific antibodies and uses thereof
US-2025064927-A1 · Feb 27, 2025 · US
Antibody constructs for msln and cd3
US-2024400673-A1 · Dec 5, 2024 · US
Nucleic acids encoding anitbody constructs binding EGFR VIII and CD3
US-12152078-B2 · Nov 26, 2024 · US
Multitargeting bispecific antigen-binding molecules of increased selectivity
US-2024209078-A1 · Jun 27, 2024 · US
Single chain binding molecules comprising N-terminal ABP
US-2024166761-A1 · May 23, 2024 · US
Cross-species-specific single domain bispecific single chain antibody
US-11987633-B2 · May 21, 2024 · US
Bispecific antibody constructs for CDH3 and CD3
US-11926666-B2 · Mar 12, 2024 · US
Compositions comprising cross-species-specific antibodies and uses thereof
US-11925684-B2 · Mar 12, 2024 · US
Antibody constructs for MSLN and CD3
US-11884720-B2 · Jan 30, 2024 · US
Antibody Constructs for CDH19 and CD3
US-2024010724-A1 · Jan 11, 2024 · US
Methods for administering therapeutic doses of bispecific t-cell engaging molecules for the treatment of cancer
US-2023398147-A1 · Dec 14, 2023 · US
Cross-species-specific binding domain
US-2023357444-A1 · Nov 9, 2023 · US
Antibody constructs for dll3 and cd3
US-2023312717-A1 · Oct 5, 2023 · US
Bispecific t cell engaging antibody constructs
US-2023192884-A1 · Jun 22, 2023 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Amgen Res Munich Gmbh | 113 |
| Amgen Inc | 34 |
| Boehringer Ingelheim Int | 7 |
| Kufer Peter | 4 |
| Klinger Matthias | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/31 | 110 |
| A61P35/00 | 102 |
| C07K16/2809 | 102 |
| C07K2317/622 | 91 |
| A61K2039/505 | 79 |